oritavancin

Term ID

CHEBI:82699

Synonyms

• (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(3'')-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin
• (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin
• Chlorobiphenyl-chloroeremomycin
• LY333328

Definition

A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.

References

• cas:171099-57-3
• drugcentral:4678
• kegg.compound:C12034
• pubmed:22941898
• pubmed:23089749
• pubmed:23261897
• pubmed:23759507
• pubmed:24035967
• pubmed:24449768
• pubmed:24505091
• pubmed:24550323
• pubmed:24897083
• pubmed:24906505
• pubmed:25022588
• pubmed:25058176
• pubmed:25118105
• pubmed:25239268
• pubmed:25294250
• pubmed:25294303
• reaxys:7608605
• wikipedia.en:Oritavancin

Ontology

ChEBI  ( EBI )